Tian Rui Xingtong

Chengdu Tianrui Xingtong Technology Co., LTD., founded in 2013, is a private high-tech enterprise focusing on microwave, millimeter wave active phased array chip and antenna.

PINS Medical

PINS Medical is a high-tech enterprise specializing in the research and development, production and sales of cerebral pacemaker, vagus nerve stimulator, spinal cord stimulator, sacral nerve stimulator and other serialized neuroregulatory products.

Surgerii robotics

Surgerii Robot is a high-tech enterprise committed to completely independent research and development, production and sales of single/porous universal minimally invasive endoscopic surgery robot system.


Huake Precision is a leading company developing intelligent surgery platform for minimally invasive precision treatment in neurosurgery in China.


Binhui Biopharm is a leading oncolytic drug research and development enterprise in China. The company has the only founding team with successful experience in the research and development of oncolytic virus in China. The founder Liu Binlei is the core original researcher of FDA's first oncolytic virus T-VEC.


Xuanzhu Biology is an innovative biopharmaceutical company rooted in China with a global perspective, focusing on the fields of cancer, metabolic diseases, infection and so on.


Hinova is one of the fastest growing start-up drug discovery and development companies in China.


Headquartered in Beijing, CANbridge is a global bio-pharmaceutical company with a mission to accelerate development and commercialization of life-changing specialty healthcare products in China and North Asia.


Geneseeq established in 2008, is an industry leader in Next-Generation Sequencing (NGS) fully committed to the research and clinical translation of NGS Genetic Sequencing in the field of personalized medicine.

Todaysoft Gene

Todaysoft Gene is a national high-tech enterprise that uses internet and cloud computing technology to achieve the acquisition and application of tumor precise medical clinical big data.


Cyrano is developing an intranasal therapy using theophylline to treat loss of smell (hyposmia), a condition that affects 14 million in the US caused by a respiratory viral infection or sinusitis and for which there is no existing pharmaceutical treatment. Intranasal theophylline has been shown to be very effective in a pilot clinical trial.


Angioslide Ltd., founded in 2005, is a privately-held medical device company dedicated to provide physicians with cost effective, innovative products for emboli management during vascular interventions.


Founded in California, United States, Metronom Health, Inc. is engaged in developing a Continuous Glucose Monitor (“CGM”) based on an optical sensor.


Sonendo, Inc., located in California, United States, develops innovative and disruptive technologies to transform traditional endodontic therapy.


Mitrallign, based in the USA, produces the only direct transcatheter annuloplasty system designed to treat both tricuspid and mitral regurgitation as a market leader.


Vessix is based in California, USA. Vessix Renal denervation is an emerging, minimally-invasive, catheter-based approach to treat uncontrolled hypertension. Vessix had been acquired by Boston Scientific Corporation.


TruTag develops innovative, cost-effective and practical solutions using TruTag microtags made of silicon dioxide, or silica. TruTag was selected by the World Economic Forum as Technology Pioneer (2014).

Enlife Service

Enife Service, founded in 2008, is the pioneer of China’s third-party supervision and management of food safety.






Sorrento Therapeutics (NASDAQ:SRNE) is a San Diego based, revenue-generating, multi-strategy biopharmaceutical company engaged in discovery, acquisition,and development of therapeutic candidates in oncology.



Yingliu Electrome

Yingliu Electrome(603308.SH)



Poly Pharm

Poly Pharm(300630.SZ)





APT Electronics

APT Electronics Co., Limited (836789.OC)was founded in August, 2006 in Nansha, Guangzhou. APT with a registered capital of 319 million RMB, and a total investment is up to 1.5 billion RMB. APT possesses an area of 35,000 square meters as manufacturing pla